Pacing in Patients with Congenital Heart Disease: When Is It Helpful and When Is It Harmful?

M David Weiland1, Zebulon Spector2, Salim F Idriss3

  • 1Pediatric Cardiology and Electrophysiology, University of Mississippi Medical Center, Jackson, MS, 39216, USA.

Insights

Pacing for congenital heart disease (CHD) patients needs careful, individualized planning. A thorough risk/benefit analysis is crucial for successful pacing outcomes in this growing patient group.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Electrophysiology

Background:

  • Congenital heart disease (CHD) affects a growing population requiring specialized medical interventions.
  • Pacing is a critical therapy for managing arrhythmias in patients with CHD.
  • Existing guidelines for pacing in CHD patients are evolving, necessitating updated approaches.

Purpose of the Study:

  • To review current guidelines and best practices for pacing in pediatric and adult patients with CHD.
  • To emphasize the importance of individualized care and risk/benefit assessment in pacing decisions for CHD patients.

Main Methods:

  • Review of current consensus statements and summary guidelines on cardiac pacing.
  • Analysis of decision-making processes for pacing in pediatric and adult CHD populations.
  • Case-by-case evaluation of risk and benefit for pacing strategies.

Main Results:

  • Pacing in CHD patients requires careful consideration of both pediatric and adult guidelines.
  • Individualized care plans are essential for maximizing success and minimizing risks.
  • Risk/benefit assessment is paramount in determining the optimal pacing strategy.

Conclusions:

  • Effective pacing in CHD patients hinges on meticulous evaluation and tailored treatment plans.
  • Integrating historical pediatric recommendations with current adult guidelines ensures comprehensive care.
  • Proactive, individualized pacing strategies are key to favorable outcomes in this specialized population.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
785
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
342